Advertisement
House Committees Launch Investigation Into Alzheimer's Drug
ResumeTwo House committees are now investigating the drug aducanumab, which was approved by the Food and Drug Administration to treat Alzheimer's disease.
Here & Now's Peter O'Dowd talks with Damian Garde, a reporter at STAT.
This segment aired on July 1, 2021.